Clinical Trial Update: Tenecteplase (TNK) in the Treatment of Intracerebral Hemorrhage (ICH) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update evaluating the use of tenecteplase (TNK) for treating intracerebral hemorrhage, with the study currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhagic Stroke
• Intracerebral Hemorrhage
• Intracranial Hemorrhage

Drugs mentioned

• Tenecteplase (tenecteplase)

Snippet

Sponsor: Gaurav Gupta, MD | Conditions: Intracerebral Hemorrhage, Intracranial Hemorrhages | Phase 1 | Status: NOT_YET_RECRUITING